Blood Collection Market by Product (Blood Collection Needles and Syringes, Blood Collection Tubes {EDTA, Heparin, Serum-separating Tubes, and Plasma-separating Tubes}, Blood Lancets, Blood Bags, Vials, and Others), Application (Diagnostics {Infectious Diseases and Non-infectious Diseases} and Treatment), and End User (Hospitals & Diagnostic Centers, Blood Banks, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025

Get 20% Free Customization In This Report

Diagnostics and Biotech	LI_184360	Pages: NA	Jun 2019 \| 878 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Blood is collected as whole blood (WB) by blood donation processes, and later it can be separated into various components by a process called as apheresis. The amount of blood drawn varies and should not be more than 1% of the body weight of the donor. The collection can be done with help of an automated equipment that collects only specific components of blood or blood can also be collected manually.

The growth of the blood collection market is driven by rise in incidence of trauma and accidents, and surge in number of surgical procedures carried out worldwide. In addition, growth in awareness increase in government initiatives about blood donation and are expected to boost the demand for blood collection products. However, risks related to blood transfusion in underdeveloped countries impede this growth.

The global blood collection market is segmented based on product, application, end user, and region. Based on product, it is classified into blood collection needles and syringes, blood collection tubes, blood lancets, blood bags, vials, and others. Blood collection tubes are further categorized into EDTA, heparin, serum-separating tubes, and plasma-separating tubes. Based on application, the market is divided into diagnostics and treatment. Diagnostics application is further bifurcated into infectious diseases and non-infectious diseases. By end user, the market is categorized into hospitals & diagnostic centers, blood banks, and others.

Based on region, it is analyzed across North America, Europe, Asia Pacific, and LAMEA. These regions are further analyzed at the country level to determine the market size and forecast for each segment and sub-segment.

Comprehensive competitive analysis and profiles of major players, such as Abbott Laboratories Inc., Medtronic, Becton Dickinson and Company, Terumo Corporation, Nipro Medical Corporation, Qiagen, F.L. Medical SRL, Greiner Holding AG, Haemonetics Corporation, and Sarstedt AG & Co., are provided in this report.

Key Benefits

The study provides an in-depth analysis, current trends, and future estimations of the global blood collection market to elucidate the imminent investment pockets.
Extensive analysis is conducted by following key player positioning and monitoring the top competitors within the market framework.
It offers a quantitative analysis from 2017 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

Blood Collection Market Key Segments:

By Product

Blood Collection Needles and Syringes
Blood Collection Tubes
- EDTA
- Heparin
- Serum-separating Tubes
- Plasma-separating Tubes
Blood Lancets
Blood Bags
Vials
Others

By Application

Diagnostics
- Infectious Diseases
- Non-infectious Diseases
Treatment

By End User

Hospitals & Diagnostic Centers
Blood Banks
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA

"Note : The list of companies mentioned in the description is tentative in nature and may change after detailed analysis."

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 GLOBAL BLOOD COLLECTION MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. BLOOD COLLECTION NEEDLES AND SYRINGES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. BLOOD COLLECTION TUBES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. EDTA
4.3.5. Heparin
4.3.6. Serum-separating Tubes
4.3.7. Plasma-separating Tubes

4.4. BLOOD LANCETS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. BLOOD BAGS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

4.6. VIALS

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

4.7. OTHERS

4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast

Chapter: 5 GLOBAL BLOOD COLLECTION MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. DIAGNOSTICS

5.2.1. Market size and forecast

5.2.2. Infectious Diseases

5.2.3. Non-infectious Diseases

5.3. TREATMENT

5.3.1. Market size and forecast

Chapter: 6 GLOBAL BLOOD COLLECTION MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS AND DIAGNOSTIC CENTERS

6.2.1. Market size and forecast

6.3. BLOOD BANKS

6.3.1. Market size and forecast

6.4. OTHER END USERS

6.4.1. Market size and forecast

Chapter: 7 BLOOD COLLECTION MARKET, BY GEOGRAPHY

7.1. OVERVIEW
7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. South Africa market size and forecast
7.5.3.5. Rest of LAMEA market size and forecast

Chapter: 8 COMPANY PROFILES

8.1. ABBOTT LABORATORIES

8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments

8.2. MEDTRONIC

8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments

8.3. BECTON DICKINSON AND COMPANY

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.4. TERUMO CORPORATION

8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. NIPRO MEDICAL CORPORATION

8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments

8.6. QIAGEN

8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. F.L. MEDICAL SRL

8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments

8.8. GREINER HOLDING AG

8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments

8.9. HAEMONETICS CORPORATION

8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments

8.10. SARSTEDT AG & CO

8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

"Note : The list of companies mentioned in the description is tentative in nature and may change after detailed analysis."

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Blood Collection Market Key Segments:

By Product

By Application

By End User

By Region

PURCHASE OPTIONS

Reach out to us

Request TOC/Sample

Request Customization

Request TOC/Sample

Why Allied Market Research

Infallible Methodology

Analyst Support

Customization

TARGETED MARKET VIEW

Featured Reports

Featured Readings

Get Fresh content delivered

About

Contact Us

Find Help

Get notification about our new releases

Our Products & Services

CONNECT WITH US

Press Media

We Accept